News Story: Full Text
Sponsored By
Genentech Biooncology
Please Click On The Above Banner For More Details
Braintumor Website


Boston Life Sciences Announces Expansion of Clinical Program in ADHD Diagnosis (Business Wire) ... physiologic/biochemical abnormality (increased numbers of DATs) in certain regions of the brain, and that this abnormality could be detected and measured using Altropane as an objective test....... a naturally-occurring anti-angiogenesis factor for the treatment of solid tumors AF-1 and Inosine, nerve growth factors for the treatment of acute and chronic CNS disorders;... - Aug 20 2:10 PM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557